| For: | Zhou DQ, Liu JY, Zhao F, Zhang J, Liu LL, Jia JR, Cao ZH. Risk factors for hepatocellular carcinoma in cirrhosis: A comprehensive analysis from a decade-long study. World J Gastrointest Oncol 2024; 16(12): 4625-4635 [PMID: 39678801 DOI: 10.4251/wjgo.v16.i12.4625] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i12/4625.htm |
| Number | Citing Articles |
| 1 |
Xiaojia Guo, Yuanyuan Xie, Rongmin Qian, Jing Li, Junling Shi, Qingsheng Huang, Dongyan Shao. Mechanical microenvironment and its role in hepatocellular carcinoma oncogenesis and progression. Critical Reviews in Oncology/Hematology 2026; 218: 105099 doi: 10.1016/j.critrevonc.2025.105099
|
| 2 |
Jing Zeng, Ganhua Zeng. Posttreatment FIB-4 score change predicts hepatocellular carcinoma in chronic hepatitis C patients. Journal of the Formosan Medical Association 2025; doi: 10.1016/j.jfma.2025.04.001
|
| 3 |
Hitomi Takada, Nobuharu Tamaki, Hironori Ochi, Nami Mori, Keiji Tsuji, Toshifumi Tada, Shinichiro Nakamura, Junichi Toshimori, Naoki Yoshioka, Hirotaka Arai, Hideki Fujii, Chitomi Hasebe, Toshimitsu Murohisa, Eisuke Okamoto, Masahiko Kondo, Hiroyuki Marusawa, Naohito Urawa, Takuto Yoshioka, Hideo Yoshida, Ryoichi Narita, Takehiro Akahane, Atsunori Kusakabe, Michiko Nonogi, Ryosuke Imado, Yasushi Uchida, Takashi Sato, Keisuke Yokohama, Yoshihito Kubotsu, Toru Ishii, Namiki Izumi, Masayuki Kurosaki. Sofosbuvir/Velpatasvir in Chronic Hepatitis C, Compensated and Decompensated Cirrhosis, and Retreatment Settings. Internal Medicine 2026; doi: 10.2169/internalmedicine.6497-25
|
